HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57:M64-M70 (2002)
© 2002 The Gerontological Society of America

The {tau} Protein of Oral Epithelium Increases in Alzheimer's Disease

Hideyuki Hattoria, Masayuki Matsumotoa, Kunimitu Iwaia, Hiroshi Tsuchiyaa, Eiji Miyauchia, Mikihiro Takasakia, Kouzin Kaminoa, Junichi Munehiraa, Yasuhiro Kimuraa, Kenichi Kawanishia, Tomoko Hoshinoa, Hiroshi Muraia, Hajime Ogataa, Hidemichi Maruyamaa and Hiroshi Yoshidab

a Department of Geriatric Medicine, Kanazawa Medical University, Ishikawa, Japan
b Diagnostic Department of Research and Development Center, Nissho Corporation, Shiga, Japan

Hideyuki Hattori, Department of Geriatric Medicine, Kanazawa Medical University, Daigaku 1-1, Uchinada-Machi, Kahoku-Gun, Ishikawa 920-0293, Japan E-mail: hideyuki{at}kanazawa-med.ac.jp.

Decision Editor: John E. Morley, MB, BCh

Background. Alzheimer's disease (AD) is an important problem that should be solved in the 21st century. Prior to treatment, a simple and easy diagnostic method using biological markers should be available. As a method to attain this goal, we detected and determined {tau} protein in oral mucosal epithelium.

Methods. Oral epithelium was exfoliated from 34 patients with AD or 29 patients with vascular dementia, and 33 young and 34 age-matched controls. Western blot was performed for determining the molecular weight of oral {tau} protein. The {tau} protein level was determined with an enzyme-linked immunosorbent assay (ELISA) kit for cerebrospinal fluid (CSF). CSF {tau} was also measured and compared with oral {tau}.

Results. Western blot analysis using an anti–non-phosphorylated {tau}-protein antibody showed two bands, one at 65 Kd and the other at 110 Kd. The {tau}-protein level in oral epithelia showed a significant positive correlation with those in the CSF (p < .05). The patients with AD had significantly higher levels of {tau} protein than the patients with vascular dementia and the controls (p < .01). AD patients with a younger age at onset of the study showed a higher level of the {tau} protein than the patients with later age at onset (p < .05).

Conclusions. Like other nonneural tissues, oral epithelium contains small {tau} and big {tau}. The {tau} protein in oral epithelium reflects the pathological changes, as does the CSF {tau}. Individuals who develop AD may have had high levels of the {tau} protein in oral mucosal epithelium since early childhood. The {tau}-protein level in oral epithelia could be helpful in diagnosing AD.




This article has been cited by other articles:


Home page
MutagenesisHome page
P. Thomas, J. Hecker, J. Faunt, and M. Fenech
Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease
Mutagenesis, November 1, 2007; 22(6): 371 - 379.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Rouzier, R. Rajan, P. Wagner, K. R. Hess, D. L. Gold, J. Stec, M. Ayers, J. S. Ross, P. Zhang, T. A. Buchholz, et al.
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
PNAS, June 7, 2005; 102(23): 8315 - 8320.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
W. A. Banks and J. E. Morley
Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M314 - 321.
[Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The Gerontological Society of America.